Imfinzi (durvalumab) - AstraZeneca
Tecentriq (atezolizumab) - Roche
Zumrad (sasanlimab) - Pfizer
http://www.ncbi.nlm.nih.gov/pubmed/42697960
 
Frank Vom Dorp; Georgios Gakis
 
Sep 6, 2026
 
Prev Next